Deaths Tied to 'Fake Xanax' Street Drug Are Soaring
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
THURSDAY, Jan. 4, 2024 -- Three twenty-somethings in Chicago took a street drug they thought was a harmless form of Xanax.
All three were found collapsed and unresponsive eight hours later by one of their mothers, who had them rushed to the hospital.
After multiple seizures, fever and heart damage, all three are thought to have recovered, but not before spending many days hospitalized.
According to a new report, the drug they actually took was an unapproved benzodiazepine sedative called bromazolam, with street names like "Fake Xanax" and "Dope."
It's increasingly being distributed illicitly online or on the street and, when mixed with fentanyl, is also fueling a rising number of deaths.
Law enforcement drug seizures in the United States involving bromazolam have soared from only a handful in 2018 to more than 2,900 by 2023, according to researchers led by Dr. Paul Ehlers, a toxicologist at Cook County Hospital in Chicago.
"In Illinois, bromazolam-involved deaths increased from 10 in 2021 to 51 in 2022," a five-fold increase in just one year, the team noted.
Bromazolam is showing up in other states, too.
“It’s a very powerful drug, and when you mix a drug like that and mix it with fentanyl and some of the other opiates, it’s just a recipe for disaster,” Hamilton County Coroner Jeff Jellison told Indiana's Fox59 News in December.
In a Facebook post, he said signs of dangerous bromazolam use can include "loss of coordination, dizziness, drowsiness, blurred vision, slurred speech, muscle relaxation, difficulty breathing, amnesia and death."
The three cases noted in the Chicago report occurred early in 2023 and, luckily, fentanyl was not involved. All three young people experienced multiple, recurrent seizures and required tubes while in the ICU to help maintain breathing. All showed evidence of heart damage caused by their experience.
Two of the patients, both males aged 25, recovered and were discharged after four days and 11 days of hospital care.
The youngest patient, a 20-year-old woman, developed a form of epilepsy and fell into a coma. After 11 days in one hospital she was transferred to another hospital, after which her history is unknown, Ehler's group said.
The report also notes that bromazolam is increasingly showing up in DUI cases, because of its sedating effect on drivers.
Ehler's team are alerting doctors, EMS crews and health officials to be on the lookout for overdoses involving bromazolam, especially when seizures and fever are present.
The report was published in the Jan. 5 issue of Morbidity and Mortality Weekly Report, a journal of the U.S. Centers for Disease Control and Prevention.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-05 04:15
Read more
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- Preventing, Treating Sports Injuries in Kids: A Guide
- Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
- Bird Flu Infection Confirmed in a Pig for First Time in U.S.
- Childbirth Can Bring Worrying Medical Bills, Even With Insurance
- Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions